Global Alopecia (Hair Loss Treatment) market is expected to grow from US$ 978 million in 2025 to US$ 1439 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.

Global Alopecia (Hair Loss Treatment) Market Size and Outlook 2025-31

The global Alopecia (Hair Loss Treatment) market size is predicted to grow from US$ 978 million in 2025 to US$ 1439 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Hair loss (alopecia) can affect just your scalp or your entire body, and it can be temporary or permanent. It can be the result of heredity, hormonal changes, medical conditions or a normal part of aging. Anyone can lose hair on their head, but its more common in men. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Alopecia (Hair Loss Treatment) Industry Forecast looks at past sales and reviews total world Alopecia (Hair Loss Treatment) sales in 2024, providing a comprehensive analysis by region and market sector of projected Alopecia (Hair Loss Treatment) sales for 2025 through 2031. With Alopecia (Hair Loss Treatment) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alopecia (Hair Loss Treatment) industry. This Insight Report provides a comprehensive analysis of the global Alopecia (Hair Loss Treatment) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alopecia (Hair Loss Treatment) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Alopecia (Hair Loss Treatment) market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alopecia (Hair Loss Treatment) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alopecia (Hair Loss Treatment). This report presents a comprehensive overview, market shares, and growth opportunities of Alopecia (Hair Loss Treatment) market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Shampoos and Conditioners &nbsp;&nbsp;&nbsp; Medicine Product Segmentation by Application: &nbsp;&nbsp;&nbsp; Men &nbsp;&nbsp;&nbsp; Women This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Shiseido &nbsp;&nbsp;&nbsp; Rohto &nbsp;&nbsp;&nbsp; Unilever &nbsp;&nbsp;&nbsp; Taisho &nbsp;&nbsp;&nbsp; Angfa &nbsp;&nbsp;&nbsp; LOreal &nbsp;&nbsp;&nbsp; Kaminomoto &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Yanagiya Honten &nbsp;&nbsp;&nbsp; Amorepacific &nbsp;&nbsp;&nbsp; Procter & Gamble &nbsp;&nbsp;&nbsp; Himalaya &nbsp;&nbsp;&nbsp; Gerolymatos International &nbsp;&nbsp;&nbsp; Merz Pharma &nbsp;&nbsp;&nbsp; Leader Teck &nbsp;&nbsp;&nbsp; Vasu Healthcare &nbsp;&nbsp;&nbsp; VLCC &nbsp;&nbsp;&nbsp; Ales Group &nbsp;&nbsp;&nbsp; Shanxi Ante &nbsp;&nbsp;&nbsp; Wansheng Pharmaceutical &nbsp;&nbsp;&nbsp; Advanced Skin and Hair &nbsp;&nbsp;&nbsp; Humanwell Healthcare &nbsp;&nbsp;&nbsp; Topfond &nbsp;&nbsp;&nbsp; Lifes2good &nbsp;&nbsp;&nbsp; Bawang &nbsp;&nbsp;&nbsp; YNK Pharmaceutical &nbsp;&nbsp;&nbsp; Apollo &nbsp;&nbsp;&nbsp; Jingxiutang &nbsp;&nbsp;&nbsp; Rogaine &nbsp;&nbsp;&nbsp; Marico Key Questions Addressed in this Report What is the 10-year outlook for the global Alopecia (Hair Loss Treatment) market? What factors are driving Alopecia (Hair Loss Treatment) market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Alopecia (Hair Loss Treatment) market opportunities vary by end market size? How does Alopecia (Hair Loss Treatment) break out by Type, by Application?

Report	Global Alopecia (Hair Loss Treatment) Market Growth 2025-2031
Selected License	Single ID:LPI24924

Buyer Information

Order Summary